EUROPEAN UNION Issue dated 14/02/2002

Lobby Pushes for System for Pediatric Drugs

The big pharmaceutical groups want the European Union to create specific intellectual property rights for pediatric medicines. They argue that the R&D costs are the same as for adult medicines but demand is less permanent. [...] (264 words)
This article may be accessed by subscribers and e-wallet holders (EUR 6)
Log in to read more

Subscribe or Pay-Per-Article
Discover our offers

New: Sign up for real-time alerts and be notified of new editions!  

Once registered, you will be notified by a short message on your computer or mobile phone as soon as a new edition of our publication or an alert is published. Stay informed anytime, anywhere!

By continuing your visit to this site, you accept the use of cookies allowing us to adapt and enhance your experience. Read more